A newly identified compound activating UCP1 inhibits obesity and its related metabolic disorders

CONCLUSIONS: The identified compound can serve as a potential therapeutic drug for the treatment of obesity and its related metabolic disorders. Furthermore, our newly clarified thermogenic genes play an important role in UCP1-dependent thermogenesis in adipocytes.PMID:37974549 | DOI:10.1002/oby.23948

https://pubmed.ncbi.nlm.nih.gov/37974549/?utm_source=no_user_agent&utm_medium=rs...

Source: Obesity - November 17, 2023 Category: Eating Disorders & Weight Management Authors: Ken Onodera Yutaka Hasegawa Nozomi Yokota Shukuko Tamura Hirofumi Kinno Iwao Takahashi Hiraku Chiba Hirotatsu Kojima Hideki Katagiri Koji Nata Yasushi Ishigaki Source Type: research